Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Graymatters

Request full access

EEG-based self-neuromodulation therapy for mental health disorders

Haifa, IsraelFounded 2018Biotech & Life Sciences

About Graymatters

Developer of digital therapeutics designed to cure mental illness. The company's digital therapeutics follow the self-regulation of brain processes to solve the issues related to mental health and neurologic disorder, enabling patients suffering from neurological disorders to treat their diseases in a hassle-free manner.

Source: Dealroom company data

At a glance

Status
Operational
Employees
31
Open positions
None listed
Dealroom signal
66.0/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices, Health Platform
Sector
Psychology, Biotechnology, Mental Health, Spinout, EIC, Digital Therapeutics, Biotech and Pharma
Technology
Deep Tech
Business model
SaaS
Client focus
B2B

Funding history

7 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SUPPORT PROGRAM✓Other financing Nov 2022 $0 — Undisclosed —
SUPPORT PROGRAM✓Other financing Jan 2022 $0 — 28DIGITAL Accelerator —
Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Growth signals

Graymatters website traffic

Latest recorded traffic for Graymatters is 9.2K monthly website visits, up 196.8% over the last three months. Graymatters's team grew 6.9% over the past year.

Latest monthly visits9.2K 3-month web change+196.8% 1-year team growth+6.9%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Graymatters in the Haifa ecosystem

Live from Dealroom

The Graymatters office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

15 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • Joyance Partners
  • European Innovation Council

Series A7 investors entered at this stage

  • EIC Fund
  • Otsuka Pharmaceutical
  • Marius Nacht
  • J-Impact
  • GMH Ventures
  • Joy Ventures
  • J-Ventures

Other known investors6 additional known investors

  • 28DIGITAL Accelerator
  • Tel Aviv Sourasky Medical Center
  • Tel Aviv University
  • Endless Frontier Labs
  • Falling Walls Foundation
  • J Ventures
Team profiled 12 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 6 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See Graymatters’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.